Atosiban treatment for uterine hyperactivity during active labor: A pilot study

Journal of Perinatal Medicine

Volumn 32, Issue 2, 2004, Pages 137-139

  Lurie, Samuel ^a   Sadan, Oscar ^b   Aroya, Zahi Ben ^b   Glezerman, Marek ^b  

^a WOLFSON MEDICAL CENTER   (Israel)

^b NONE

Author keywords

Atosiban; Labor; Tocolysis; Uterine hyperactivity

Indexed keywords

ATOSIBAN; RITODRINE; TERBUTALINE; ARGIPRESTOCIN; DRUG DERIVATIVE; UTERUS SPASMOLYTIC AGENT;

ADULT; APGAR SCORE; ARTICLE; CESAREAN SECTION; DRUG EFFECT; DRUG TOLERABILITY; FEMALE; FETUS HEART RATE; HUMAN; HUMAN EXPERIMENT; LABOR; NEWBORN HYPOXIA; NORMAL HUMAN; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESUSCITATION; SIDE EFFECT; TOCOLYSIS; UTERUS CONTRACTILITY; CLINICAL TRIAL; DYSTOCIA; INTRAVENOUS DRUG ADMINISTRATION; PREGNANCY; THIRD TRIMESTER PREGNANCY; UTERUS CONTRACTION;

ADULT; DYSTOCIA; FEMALE; HEART RATE, FETAL; HUMANS; INJECTIONS, INTRAVENOUS; PILOT PROJECTS; PREGNANCY; PREGNANCY TRIMESTER, THIRD; PROSPECTIVE STUDIES; TOCOLYTIC AGENTS; UTERINE CONTRACTION; VASOTOCIN;

EID: 2942642366     PISSN: 03005577     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPM.2004.025     Document Type: Article

References (8)

1. Melin P: Development of an oxytocin antagonist atosiban. Res Clin Forum 16 (1994) 155
2. Mercier FJ, M Dounas, H Bouaziz, C Lhuissier, D Benhamou. Intravenous nitroglycerin to relieve intrapartum fetal distress related to uterine hyperactivity: a prospective observational study. Anesth Analg 84 (1997) 1117
3. Moutquin JM, D Sherman, H Cohen, et al.: Double-blind, randomized, controlled trial of Atosiban and Ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study. Am J Obstet Gynecol 182 (2000) 1191
4. Pryde PG, RE Besinger, JG Gianopoulos, R Mittendorf: Adverse and beneficial effects of tocolytic therapy. Semin Perinatol 25 (2001) 316
5. Tejani NA, UL Verma, S Chatterjee, S Mittelmann: Terbutaline in the management of acute intrapartum fetal acidosis. J Reprod Med 28 (1983) 857
6. The Worldwide Atosiban versus Beta-agonists Study Group. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group. BJOG 108 (2001) 133
7. Vigil-De Gracia P, E Simiti, Y Lora: Intrapartum fetal distress and magnesium sulfate. Int J Gynaecol Obstet 68 (2000) 3
8. Zalel Y, Z Katz, I Blickstein, A Friedman, M Mogilner, M Lancet: Ritodrine treatment for uterine hyperactivity during the active phase of labor. Int J Gynaecol Obstet 31 (1990) 237